FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4212111000001101: Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21834501000001113 Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
42826801000001116 Progesterone 8% vaginal gel 1.125g applicators 15 unit dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Is pack of Product containing precisely progesterone 80 milligram/1 gram conventional release vaginal gel (clinical drug) false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has VMP Progesterone 8% vaginal gel 1.125g applicators true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has manufactured dose form Gel false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has VMP Product containing precisely progesterone 80 milligram/1 gram conventional release vaginal gel (clinical drug) false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has specific active ingredient Progesterone true Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has dispensed dose form Gel false Inferred relationship Existential restriction modifier
Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Has dispensed dose form Conventional release vaginal gel true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Crinone 8% progesterone vaginal gel (Serono Laboratories (UK) Ltd) 15 unit dose Is a True Progesterone 8% vaginal gel 1.125gram applicators 15 unit dose Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start